Federal prosecutors say the Van Nuys hospice owner directed a sprawling billing operation involving medically unnecessary services, deceased beneficiaries, unlawful referral payments, identity misuse, false records, and nearly $27 million paid by Medicare across four Southern California providers
WASHINGTON, DC — Oren David Shachar, a 59-year-old Van Nuys healthcare business owner, was arrested in Los Angeles on June 18 and accused of directing an alleged Medicare hospice fraud operation that federal prosecutors say generated approximately $27.7 million in false claims.
The Justice Department announcement describing the Southern California healthcare fraud cases states that Shachar and alleged co-defendant Abraham Shin made their initial appearances and were arraigned in federal court on the day authorities arrested them.
Federal prosecutors allege that Shachar controlled four hospice companies, recruited beneficiaries who were not terminally ill, used information belonging to deceased people, paid referral kickbacks, created false records, and converted Medicare reimbursements into personal financial benefits.
Shachar, Shin, and alleged co-defendant Jeannie Choi remain presumed innocent, while every accusation concerning fraudulent billing, medical necessity, patient recruitment, identity misuse, kickbacks, money laundering, or false documentation must be proven beyond a reasonable doubt in federal court.
The Arrest Followed a Sixteen-Count Indictment
The arrest brought Shachar before a federal magistrate judge two days after a grand jury returned a sixteen-count indictment charging a conspiracy, eight healthcare fraud executions, three aggravated identity theft offenses, a financial transaction involving alleged criminal proceeds, and additional kickback violations.
Authorities arrested Shin alongside Shachar, while Choi was arrested several days later, and the Justice Department said a magistrate judge ordered Shachar and Shin released on bond following their first federal court proceedings in Los Angeles.
An arrest establishes that prosecutors have initiated a criminal case under judicial authority, but it does not establish guilt, validate every allegation in an indictment, or prevent defense lawyers from challenging searches, witnesses, documents, expert opinions, and statutory interpretations.
The publicly announced case immediately attracted attention because it combines a large Medicare billing total with allegations involving terminally ill patients, deceased beneficiaries, funeral-home information, electronic medical records, luxury spending, and payments allegedly designed to generate continuing hospice enrollments.
Four Hospice Companies Anchor the Government’s Theory
Prosecutors identify Gentle Touch Hospice Care in Valley Glen, Oxford Hospice Care in Montclair, Art of Hospice in Encino, and Holly Trinity Hospice in Glendale as the four businesses Shachar allegedly owned, controlled, or operated during relevant periods.
The indictment traces Shachar’s alleged control of those companies through corporate filings, Medicare records, ownership agreements, enrollment applications, bank accounts, and business locations, creating a multi-company framework for conduct prosecutors place between February 2021 and March 2026.
That structure matters because prosecutors must connect Shachar with decisions made across separate legal entities, while defense counsel can examine whether physicians, nurses, marketers, billing contractors, administrators, or other owners exercised independent authority over particular patients and claims.
Corporate control may support an inference of responsibility when combined with instructions, communications, financial transfers, and claim activity, although a title, ownership percentage, or signature alone does not automatically prove knowledge that specific medical information was false.
The Alleged Billing Reached Nearly $27.7 Million
The indictment alleges that the four hospices submitted approximately $27,731,000 in false claims for services described as medically unnecessary, ineligible for reimbursement, not delivered as represented, or procured through illegal kickbacks and bribes during the charged period.
Medicare allegedly paid approximately $26,908,000 of those claims, a distinction that responsible coverage must preserve because the amount billed describes requested reimbursement, whereas the amount paid more closely represents the public funds prosecutors say actually reached the providers.
Neither total independently proves fraud because aggregate figures must be supported by patient-specific evidence showing what was claimed, what care was provided, why the beneficiary did or did not qualify, and what each defendant allegedly knew when reimbursement was sought.
Prosecutors can use summary evidence to explain thousands of transactions, but the defense may challenge duplicate entries, adjustments, sampling assumptions, claim reversals, legitimate services, medical disagreements, or calculations that transform disputed billing data into an apparently settled loss figure.
Medicare Hospice Eligibility Is Clinically Specific
Medicare hospice coverage generally requires physician certification that a beneficiary is terminally ill, meaning the person has a life expectancy of six months or less if the illness follows its normal course, together with a valid election choosing palliative care.
Covered hospice care may include nursing, medication for pain and symptoms, medical equipment, social services, counseling, and therapy focused upon comfort, making the benefit a vital source of support for patients and families confronting life-limiting illness.
Prognosis remains an informed medical judgment rather than a mathematical certainty, so a patient who stabilizes, improves temporarily, or survives beyond six months does not automatically prove that the original certification was knowingly false when a qualified clinician signed it.
The government must therefore distinguish ordinary clinical uncertainty, incomplete documentation, regulatory error, and disputed professional judgment from deliberate fabrication, while the defense may test every diagnosis, examination, certification, recertification, service note, and medical opinion linked with charged claims.
Prosecutors Allege Ineligible Patients Were Recruited
According to the indictment, Shachar personally met Medicare beneficiaries whom he allegedly knew were not terminally ill and encouraged them to enroll by portraying hospice as a program centered upon quality-of-life improvements rather than end-of-life medical care.
Prosecutors further allege that Shachar and people working for him concealed the physician-certification requirement and failed to explain that choosing hospice could limit Medicare coverage for curative treatment related to the terminal condition and affect care from other providers.
Those accusations place election forms, enrollment scripts, brochures, recordings, interpreter records, text messages, family recollections, and staff testimony at the center of any effort to determine what prospective beneficiaries were told before they signed documents.
A beneficiary’s signature may support the defense when paperwork records informed consent, yet prosecutors can argue that a signed form carries limited weight if evidence demonstrates misleading explanations, undisclosed inducements, invalid representative authority, backdating, or inadequate comprehension.
Cash and Gifts Allegedly Encouraged Continued Enrollment
The indictment accuses Shachar of offering beneficiaries as much as $400 each month to remain enrolled, while also providing alleged inducements that included groceries, alcohol, personal-care products, medical equipment, televisions, massages, furniture, and reclining armchairs.
Prosecutors also allege that beneficiaries could receive $100 or $200 for referring additional people, creating what the government portrays as a recruitment system in which payments and useful household goods reinforced a continuing pipeline of billable Medicare enrollments.
Financial assistance can arise in compassionate healthcare settings for legitimate reasons, but its legality depends upon purpose, structure, documentation, applicable exceptions, and the connection with federally reimbursable services, making payment records and surrounding communications crucial evidence.
The defense can dispute whether particular transfers occurred, whether prosecutors characterized them accurately, whether recipients understood their purpose, or whether payments were unrelated reimbursements, while the government must prove the knowing and prohibited intent required by each charged offense.
Marketers Were Allegedly Paid According to Referral Value
Federal prosecutors say Shachar sometimes paid marketers approximately $700 for each living beneficiary during every month that Medicare was billed for that person’s purported hospice care, creating an alleged financial reward directly tied to continued enrollment and reimbursement.
The indictment attributes later participation to Shin and Choi, alleging that Shachar paid recruiters and marketers for referrals while those individuals supplied information concerning both living beneficiaries and people who had already died before supposed hospice services occurred.
Counts Fourteen and Fifteen concern two narrower transactions in which Shachar allegedly offered and paid $300 to Choi for one beneficiary referral and $300 to Shin for another, requiring separate proof concerning each payment’s timing, purpose, and recipient.
Even if prosecutors establish an unlawful referral payment, they must still prove the separate elements of healthcare fraud for charged claims, because an improper payment does not necessarily demonstrate that every referred patient lacked eligibility or received no legitimate service.
Deceased Beneficiaries Form the Most Disturbing Allegation
The indictment alleges that Shachar purchased names, birth dates, Social Security numbers, Medicare identification numbers, death details, physician information, and next-of-kin information belonging to deceased beneficiaries from Shin and Choi for use within the hospice operation.
Choi allegedly accessed identifying information through her employment at an unnamed California-licensed funeral home, after which images of documents and related details were transmitted through text and WhatsApp messages to facilitate further alleged activity.
Prosecutors say Shachar, Choi, a nurse, or others then contacted surviving relatives, gathered additional health information, requested records from recent hospital visits, and obtained signatures connected with purported hospice enrollment after the beneficiary’s death.
The government further alleges that Shachar directed a nurse, a physician, and others to create backdated electronic records falsely representing that evaluations and terminal-illness certifications occurred while those beneficiaries remained alive and eligible for enrollment.
Alleged Selection Rules Were Designed to Avoid Detection
Prosecutors claim Shachar established conditions for deceased referrals, including that the person died at home rather than inside a hospital, died within five days of a marketer’s contact, and was not already receiving hospice from another provider.
The indictment alleges that those conditions were intended to reduce regulatory scrutiny, conceal an unusually high live-discharge rate, and offset the effect of Medicare’s annual per-beneficiary spending limit by making the hospices appear to serve patients with genuine terminal needs.
Shachar allegedly paid between $1,000 and $3,000 for each deceased beneficiary who was enrolled, while insisting that the funeral business maintain accurate death times so corresponding hospice paperwork and family meetings could be arranged around those facts.
These remain unproven allegations, and defense counsel may contest who created any rule, whether reported statements were accurately interpreted, whether records reflect ordinary post-death administration, and whether Shachar knowingly authorized any false or backdated document.
Digital Evidence Could Reconstruct the Alleged Workflow
Electronic medical record systems can preserve user logins, creation times, edits, signatures, imported files, billing exports, and access histories, potentially allowing forensic specialists to compare documented care dates with deaths, hospital stays, messages, and claim submissions.
Device extractions may likewise reveal transfers of identification images, referral discussions, payment arrangements, patient details, and instructions, although prosecutors must authenticate particular devices, accounts, authors, recipients, timestamps, translations, and the completeness of conversational context.
Defense lawyers may challenge shared phones, common credentials, forwarded messages, missing segments, inaccurate clocks, software migrations, ambiguous abbreviations, or unsupported assumptions that a person named in a conversation necessarily wrote, received, understood, or approved its contents.
The strongest prosecution narrative would connect independent sources such as metadata, bank activity, medical files, Medicare claims, and witness testimony, while the defense will search for gaps showing that apparently related events involved different people or lawful purposes.
Eight Claims Become Eight Separate Fraud Counts
Counts Two through Nine identify eight claim executions dated between August 2023 and November 2025, with billed amounts ranging from approximately $220 to $6,270 across Gentle Touch, Oxford, Art of Hospice, and Holly Trinity.
The first five claim counts name Shachar alone, while the final three name Shachar, Choi, and Shin together, reflecting the indictment’s allegation that both marketers joined narrower portions of the broader activity during 2025.
Jurors must consider every count separately because proof that one claim was false does not automatically establish another claim, and evidence demonstrating Shachar’s involvement does not automatically establish the knowledge or intent attributed to Choi or Shin.
Mixed verdicts remain possible whenever the government’s evidence differs among patients, companies, dates, medical records, payments, and defendants, underscoring why the dramatic aggregate billing allegation cannot replace the individualized analysis required in a criminal prosecution.
Identity Theft Counts Carry Additional Requirements
Counts Ten through Twelve charge aggravated identity theft involving the names, Social Security numbers, and Medicare identifiers of three beneficiaries connected with the final healthcare fraud counts, adding statutory questions distinct from whether the underlying claims were medically justified.
Healthcare organizations lawfully possess sensitive identifiers for intake, treatment, billing, and record coordination, so prosecutors must prove that the defendants knowingly used, transferred, or possessed identifiers belonging to real people without lawful authority during qualifying federal offenses.
Defense counsel may examine consent forms, representative authority, data sources, access permissions, account attribution, business duties, and each defendant’s knowledge, challenging any suggestion that mere possession of protected information proves unauthorized or criminal use.
Because aggravated identity theft can produce mandatory consecutive punishment following conviction, the factual connection between each identifier and its associated healthcare fraud count may become one of the case’s most intensely litigated issues.
A Separate Count Alleges Beneficiary Numbers Were Sold
Count Sixteen accuses Shachar of selling, arranging the sale, or distributing nine Medicare beneficiary identification numbers to an unnamed physician for approximately $12,500 on March 6, 2025, without lawful authority to complete that transaction.
That accusation requires evidence establishing what information changed hands, who received it, whether payment occurred, what authority existed, and what Shachar knew, rather than relying upon the emotional force of separate allegations involving deceased beneficiaries.
Prosecutors may use messages, financial records, testimony, or device evidence to connect the alleged transfer with Shachar, while the defense may contest attribution, price, purpose, completeness, authorization, and the credibility of any cooperating witness.
The sale allegation also illustrates why Medicare identifiers carry substantial illicit value whenever they can be combined with provider credentials, supporting records, and billing access, although the government must prove this charged transaction with admissible evidence rather than general risk.
A Rolls-Royce Payment Supports the Proceeds Charge
Count Thirteen alleges that Shachar caused $15,000 to move from a Holly Trinity bank account toward a partial down payment under a lease-to-own arrangement for a Rolls-Royce Phantom, using property allegedly derived from healthcare fraud.
Luxury-vehicle evidence can make an accusation memorable, but prosecutors still must trace the money to qualifying criminal proceeds and establish Shachar’s required knowledge, rather than inviting jurors to treat expensive consumption as a substitute for proof.
The defense may identify legitimate hospice revenue within commingled funds, challenge the tracing method, dispute Shachar’s knowledge, or argue that the payment lacked the statutory connection with proven unlawful proceeds required for conviction on that count.
Judges can limit photographs, spending details, or inflammatory descriptions when their prejudicial effect outweighs legitimate evidentiary value, ensuring that a recognizable luxury brand does not overwhelm the careful financial analysis demanded by federal law.
The Case Joined a Historic National Enforcement Sweep
Shachar’s arrest formed part of a national healthcare fraud takedown in which federal authorities announced charges against approximately 450 defendants connected with more than $6.5 billion in alleged schemes spanning Medicare, Medicaid, hospice care, wound products, and other services.
Wall Street Journal coverage of the nationwide healthcare fraud crackdown described the campaign’s unprecedented scale and the government’s expanded use of data sharing, placing the Los Angeles hospice allegations inside a much broader federal enforcement strategy.
The national announcement may explain why the case received immediate publicity, but unrelated defendants, schemes, totals, and enforcement priorities cannot prove Shachar’s guilt or satisfy the government’s evidentiary burden concerning any count returned in Los Angeles.
Investigators from the Federal Bureau of Investigation and the Department of Health and Human Services inspector general’s office are handling the Shachar matter, while Justice Department fraud prosecutors are responsible for presenting the case in court.
Hospice Fraud Can Harm Patients Beyond Financial Losses
When an ineligible beneficiary is enrolled through deception, the potential harm extends beyond public reimbursement because hospice election can affect access to curative treatment, confuse primary-care relationships, expose confidential records, and place vulnerable families inside unwanted end-of-life decisions.
Legitimate hospice care remains an essential benefit that provides comfort, dignity, symptom management, equipment, and family support, making it important that enforcement reporting avoid portraying the entire profession as corrupt because several operators face serious accusations.
Alleged misuse of deceased beneficiaries creates a different injury by turning intimate medical histories and grieving relatives into components of a billing process, potentially forcing families to revisit painful events during interviews, document review, and courtroom testimony.
Taxpayer harm also matters because money paid upon false claims becomes unavailable for legitimate care, while expensive investigations, audits, prosecutions, and recovery proceedings impose additional costs long after questionable reimbursement has already left Medicare.
The Arrest Created Immediate Reputational Consequences
An arrest announcement involving deceased patients, kickbacks, identity misuse, and a Rolls-Royce can dominate search results within hours, affecting family members, employees, professional relationships, banking access, licensing attention, and community standing before any defense evidence becomes public.
Amicus International Consulting’s approach to crisis public-relations planning during serious allegations emphasizes organized assessment and controlled communication, although every statement during an active prosecution must remain truthful, preserve patient privacy, protect evidence, and stay coordinated with qualified defense counsel.
A responsible response may acknowledge the charges, explain procedural developments, affirm the presumption of innocence, and correct demonstrable reporting errors without attacking witnesses, disclosing confidential medical information, manufacturing public support, or predicting an outcome nobody can guarantee.
Longer-term reputation rebuilding after damaging publicity depends upon ensuring that verified dismissals, pleas, verdicts, sentencing findings, compliance reforms, and appellate decisions become as discoverable as the original arrest, while authentic public records remain accurately represented.
The Publicly Announced Trial Date May Change
The Justice Department initially stated that Shachar and Shin were scheduled for trial on August 11 after their release on bond, but complex federal cases frequently receive later scheduling orders addressing discovery, experts, motions, protected records, or co-defendant coordination.
A postponement would not establish weakness, wrongdoing, or strategic victory for either side because federal judges balance speedy-trial requirements with the practical time needed to examine extensive healthcare data and prepare a fair adversarial proceeding.
Reporters should confirm the controlling docket before stating that jury selection has begun, especially because an early trial date announced after arraignment can move as counsel identifies evidentiary disputes and the court resolves requests for additional preparation time.
Until a guilty plea, dismissal, or verdict changes the legal posture, Shachar remains presumed innocent and retains the right to confront witnesses, challenge government evidence, present lawful defenses, decline to testify, and require proof beyond a reasonable doubt.
Compliance Lessons Extend Across the Hospice Industry
Hospice providers should connect clinical eligibility, informed elections, representative authority, service records, death reporting, referral compensation, beneficiary assistance, identifier access, claim submission, and owner spending within one auditable system that can quickly expose inconsistent activity.
Organizations can reduce risk by preserving original records, disclosing late entries transparently, prohibiting shared credentials, deactivating former users promptly, matching beneficiary information against reliable death data, and investigating access occurring without a documented care or administrative purpose.
Marketing agreements require independent legal and compliance review because compensation linked with referrals, enrollment duration, diagnosis, expected reimbursement, or beneficiary characteristics can create substantial exposure even when the underlying provider believes its clinical services were appropriate.
Financial controls should separate payroll, reimbursements, charitable assistance, marketing costs, loans, owner distributions, and personal purchases, creating contemporaneous records that allow auditors to understand a transaction without relying upon explanations constructed after investigators arrive.
What Prosecutors Must Ultimately Prove
For the conspiracy charge, prosecutors must establish a knowing agreement to pursue healthcare fraud, while the substantive counts require proof that defendants knowingly and willfully executed particular fraudulent transactions through materially false statements, promises, or concealed facts.
The government must separately prove unauthorized use of real identities, prohibited remuneration, the sale of Medicare identifiers, and a qualifying transaction involving criminally derived property, because evidence supporting one statutory theory does not automatically satisfy another.
Shachar’s defense can challenge medical eligibility, patient understanding, signature authenticity, record timing, metadata interpretation, claim attribution, witness credibility, payment purpose, corporate authority, financial tracing, and the inferences prosecutors draw from conduct occurring across four companies.
Reasonable doubt need not arise from one explanation covering the entire indictment because weaknesses may differ among patients, claims, messages, payments, businesses, or witnesses, allowing jurors to reach separate conclusions across sixteen counts and three defendants.
An Arrest Begins the Courtroom Test
Oren David Shachar’s Los Angeles arrest transformed an investigation into a public federal prosecution, but the indictment now begins an evidentiary process rather than ending one, regardless of the scale, emotional force, or specificity of its accusations.
Prosecutors will seek to show that Shachar masterminded an integrated operation combining recruitment, inducements, medical documentation, identity acquisition, billing, and proceeds, while defense lawyers will attempt to separate those components and expose unsupported assumptions within every alleged connection.
The outcome will depend upon admissible patient records, reliable digital evidence, financial tracing, credible witnesses, sound medical analysis, and careful count-by-count deliberation, not upon the arrest headline, national enforcement publicity, aggregate claim total, or luxury-vehicle allegation alone.
Until federal proceedings produce a lawful resolution, Shachar, Shin, and Choi remain presumed innocent, even as the alleged $27 million Medicare hospice fraud case intensifies scrutiny of patient protection, provider accountability, identity security, and public healthcare spending.
